The SPDR S&P Biotech ETF (XBI) draws investors who seek high-risk, high-reward exposure to the biotech sector. In late 2025, investor sentiment remains cautiously optimistic. This reflects both strong opportunities and ongoing uncertainty. Analysts set a 12-month price target near $141.31. That suggests a 48% upside from current levels around $95. Technical indicators support this […]

Nasdaq 100 Index ETF (QQQ) is looking to complete wave (3). This article and video look at the Elliott Wave path of the ETF and target higher

Alnylam Pharmaceuticals Inc., (ALNY) discovers, develops & commercializes therapeutics based on ribonucleic acid interference. It comes under Healthcare – Biotech sector & trades as “ALNY” ticker at Nasdaq. ALNY is showing strong rally from April-2025 low in previous article & expect further rally once (4) pullback ends. It rallied more than 40% since last update […]

Hello everyone! In today’s article, we’ll examine the recent performance of NVIDIA Corp. ($NVDA) through the lens of Elliott Wave Theory. We’ll review how the rally from the April 2025 low unfolded as a 5-wave impulse followed by a 7-swing correction (WXY) and discuss our forecast for the next move. Let’s dive into the structure and expectations for this stock. 5 Wave […]

Magnificent Seven (MAGS) ETF long term outlook suggests it may soon end cycle from April 2025 low and pullback. This article looks at the Elliott Wave path

LII stock enters a wave IV corrective phase, offering potential buying opportunities before a strong bullish wave V rally resumes. Lennox International (LII) has been in a strong uptrend for many years, following a clear Elliott Wave impulsive structure. The stock recently completed wave III on the monthly chart and is now entering a corrective […]